文献速递儿童青少年精神

Nav1.8作为Pitt Hopkins综合征治疗靶点的评估

Evaluation of Nav1.8 as a therapeutic target for Pitt Hopkins Syndrome.
PubMed 文献 · Mol Psychiatry · 2022-10-12

Pitt Hopkins综合征(PTHS)是由TCF4基因突变导致的罕见孤独症谱系障碍综合征。本文提出SCN10A(编码Nav1.8电压门控钠通道)是TCF4的重要靶基因,在PTHS小鼠模型中持续上调;综述既往文献并展示新数据,提示抑制Nav1.8可 normalize 神经元功能、脑回路活动及行为异常,并主张该疗法可用于治疗PTHS。

要点

  • SCN10A(Nav1.8)是TCF4的重要靶基因,在PTHS小鼠模型中持续上调。
  • 抑制Nav1.8可改善PTHS小鼠模型的神经元功能、脑回路活动及行为异常。
  • 抑制Nav1.8被提出作为PTHS的潜在治疗策略。

核心结论

  • 抑制Nav1.8在PTHS小鼠模型中可 normalize 神经元功能、脑回路活动及行为异常,被提出作为PTHS的治疗方法。

研究设计与样本

  • 本文为观点性综述,回顾既往文献并展示新数据,评估Nav1.8作为PTHS治疗靶点。

主要发现

  • Scn10a编码的Nav1.8在PTHS小鼠模型中持续上调。
  • 抑制Nav1.8在PTHS小鼠模型中有效 normalize 神经元功能、脑回路活动及行为异常。

临床怎么用

  • 提示抑制Nav1.8可能作为PTHS的潜在治疗方向,需进一步临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pitt Hopkins Syndrome (PTHS) is a rare syndromic form of autism spectrum disorder (ASD) caused by autosomal dominant mutations in the Transcription Factor 4 (TCF4) gene. TCF4 is a basic helix-loop-helix transcription factor that is critical for neurodevelopment and brain function through its binding to cis-regulatory elements of target genes. One potential therapeutic strategy for PTHS is to identify dysregulated target genes and normalize their dysfunction. Here, we propose that SCN10A is an important target gene of TCF4 that is an applicable therapeutic approach for PTHS. Scn10a encodes the voltage-gated sodium channel Nav1.8 and is consistently shown to be upregulated in PTHS mouse models. In this perspective, we review prior literature and present novel data that suggests inhibiting Nav1.8 in PTHS mouse models is effective at normalizing neuron function, brain circuit activity and behavioral abnormalities and posit this therapeutic approach as a treatment for PTHS.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Martinowich K, Das D, Sripathy SR, et al. Evaluation of Nav1.8 as a therapeutic target for Pitt Hopkins Syndrome. Mol Psychiatry. 2022. PMID: 36224259. doi:10.1038/s41380-022-01811-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。